A case of central nervous system nocardiosis in a patient with lupus treated with belimumab.
Belimumab was approved by the United States Food and Drug Administration in March 2011 as the first biological agent for treating active systemic lupus erythematosus (SLE). To the best of our knowledge, this is the first case report regarding a patient with SLE treated with belimumab who was diagnosed with central nervous system nocardiosis.
Department of Rheumatology, Medstar Washington Hospital Center, Washington, USA.
Richard Hc
RH
Lai
Department of Rheumatology, Medstar Washington Hospital Center, Washington, USA.
Deborah
D
Kim
Department of Rheumatology, Medstar Washington Hospital Center, Washington, USA; Department of Clinical Medicine, Georgetown University Medical, Center, Washington, USA.
Florina
F
Constantinescu
Belimumab; central nervous system; lupus; norcardiosis; systemic lupus erythematosus